If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
3
Followers on Owler
Edgewise Therapeutics
is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases...
Read more
Overview
Competitors
Funding
News & Insights
Edgewise Therapeutics
is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases...
Read more
President & CEO
Kevin Koch
CEO Approval Rating
86/100
Weigh In
2017
Boulder
Colorado
Denver Metropolitan Area
Public
NASDAQ
EWTX
Pharmaceuticals & Biotechnology
Pharmaceuticals
Medical Research & Laboratories
2834
8731
NAICS listing
https://edgewisetx.com/
Annual Revenue
<$1M
Employees
60
Funding
$641M
News
Key Events
Latest News
Funding
Apr 02, 2025
PR Newswire
Edgewise Therapeutics received $200M in Post-IPO Equity Funding
Conference Presentation
Mar 11, 2025
Business Wire
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference
Follow and Get Alerts
Edgewise Therapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 10 + competitors
Trending Companies
